Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG 3350 for Treatment of Chronic Constipation
NCT03957668Phase 3Unknown
- Sponsor
- Faculty of Medicine, Universitas Indonesia
- Start
- Dec 2019
- Primary completion
- Sep 2020
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
Phase 3 trial of polyethylene glycol 3350 in chronic constipation (2 arms), sponsored by Faculty of Medicine, Universitas Indonesia. Primary endpoint: Change of number of bowel movements at 2 weeks. Status: unknown.
02
Drugs
polyethylene glycol 3350
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT03957668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03957668.